​Katharine Collins

​Katharine Collins, PhD,​ ​​​​MBiol, ​a senior program officer in the Science and Global Health R&D Fund, manages a portfolio of grants covering malaria, Strep A, vaccine and adjuvant development, and vaccine delivery. Earlier, as a malaria researcher at the University of Oxford in the UK, QIMR in Australia, and RUMC in the Netherlands, she worked across the translational research pipeline—from early vaccine design and development to clinical evaluation in malaria-endemic settings, with various projects in Burkina Faso, Kenya, The Gambia, and Mali—and co-invented the R21/Matrix-M malaria vaccine now being rolled out in Africa.